These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 26859091
1. Neurodevelopment of Preterm Infants at 24 Months After Neonatal Supplementation of a Prebiotic Mix: A Randomized Trial. van den Berg JP, Westerbeek EA, Bröring-Starre T, Garssen J, van Elburg RM. J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):270-6. PubMed ID: 26859091 [Abstract] [Full Text] [Related]
2. Neonatal modulation of serum cytokine profiles by a specific mixture of anti-inflammatory neutral and acidic oligosaccharides in preterm infants. van den Berg JP, van Zwieteren N, Westerbeek EA, Garssen J, van Elburg RM. Cytokine; 2013 Oct; 64(1):188-95. PubMed ID: 23911205 [Abstract] [Full Text] [Related]
3. The effect of neutral and acidic oligosaccharides on stool viscosity, stool frequency and stool pH in preterm infants. Westerbeek EA, Hensgens RL, Mihatsch WA, Boehm G, Lafeber HN, van Elburg RM. Acta Paediatr; 2011 Nov; 100(11):1426-31. PubMed ID: 21449921 [Abstract] [Full Text] [Related]
4. Response on Pneumococcal Vaccine in Preterm Infants After Neutral and Acidic Oligosaccharides Supplementation. van den Berg JP, Westerbeek EA, van der Klis FR, Sanders EA, Berbers GA, van Elburg RM. Pediatr Infect Dis J; 2015 Sep; 34(9):976-82. PubMed ID: 26153784 [Abstract] [Full Text] [Related]
5. The effect of enteral supplementation of a prebiotic mixture of non-human milk galacto-, fructo- and acidic oligosaccharides on intestinal permeability in preterm infants. Westerbeek EA, van den Berg A, Lafeber HN, Fetter WP, van Elburg RM. Br J Nutr; 2011 Jan; 105(2):268-74. PubMed ID: 20863418 [Abstract] [Full Text] [Related]
6. Randomised controlled trial demonstrates that fermented infant formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides reduces the incidence of infantile colic. Vandenplas Y, Ludwig T, Bouritius H, Alliet P, Forde D, Peeters S, Huet F, Hourihane J. Acta Paediatr; 2017 Jul; 106(7):1150-1158. PubMed ID: 28328065 [Abstract] [Full Text] [Related]
7. Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding. Magne F, Hachelaf W, Suau A, Boudraa G, Bouziane-Nedjadi K, Rigottier-Gois L, Touhami M, Desjeux JF, Pochart P. J Pediatr Gastroenterol Nutr; 2008 May; 46(5):580-8. PubMed ID: 18493215 [Abstract] [Full Text] [Related]
8. Fermented infant formula (with Bifidobacterium breve C50 and Streptococcus thermophilus O65) with prebiotic oligosaccharides is safe and modulates the gut microbiota towards a microbiota closer to that of breastfed infants. Béghin L, Tims S, Roelofs M, Rougé C, Oozeer R, Rakza T, Chirico G, Roeselers G, Knol J, Rozé JC, Turck D. Clin Nutr; 2021 Mar; 40(3):778-787. PubMed ID: 32893049 [Abstract] [Full Text] [Related]
9. Partly Fermented Infant Formulae With Specific Oligosaccharides Support Adequate Infant Growth and Are Well-Tolerated. Huet F, Abrahamse-Berkeveld M, Tims S, Simeoni U, Beley G, Savagner C, Vandenplas Y, Hourihane JO. J Pediatr Gastroenterol Nutr; 2016 Oct; 63(4):e43-53. PubMed ID: 27472478 [Abstract] [Full Text] [Related]
10. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial. Natalucci G, Latal B, Koller B, Rüegger C, Sick B, Held L, Bucher HU, Fauchère JC, Swiss EPO Neuroprotection Trial Group. JAMA; 2016 May 17; 315(19):2079-85. PubMed ID: 27187300 [Abstract] [Full Text] [Related]
11. Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy. Schouten B, Van Esch BC, Kormelink TG, Moro GE, Arslanoglu S, Boehm G, Knippels LM, Redegeld FA, Willemsen LE, Garssen J. Pediatr Allergy Immunol; 2011 Aug 17; 22(5):537-42. PubMed ID: 21771085 [Abstract] [Full Text] [Related]
12. Supplementation of dietary non-digestible oligosaccharides from birth onwards improve social and reduce anxiety-like behaviour in male BALB/c mice. Szklany K, Wopereis H, de Waard C, van Wageningen T, An R, van Limpt K, Knol J, Garssen J, Knippels LMJ, Belzer C, Kraneveld AD. Nutr Neurosci; 2020 Nov 17; 23(11):896-910. PubMed ID: 30871432 [Abstract] [Full Text] [Related]
13. Neurodevelopmental outcome during the first year of life in preterm infants after supplementation of a prebiotic mixture in the neonatal period: a follow-up study. LeCouffe NE, Westerbeek EA, van Schie PE, Schaaf VA, Lafeber HN, van Elburg RM. Neuropediatrics; 2014 Feb 17; 45(1):22-9. PubMed ID: 23888466 [Abstract] [Full Text] [Related]
15. Long-term outcomes of saline boluses in very preterm infants. Aslam A, Vincer M, Allen A, Imanullah S, O'Connell CM. J Neonatal Perinatal Med; 2018 Feb 17; 11(3):317-321. PubMed ID: 30040744 [Abstract] [Full Text] [Related]
16. Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants. Schlapbach LJ, Aebischer M, Adams M, Natalucci G, Bonhoeffer J, Latzin P, Nelle M, Bucher HU, Latal B, Swiss Neonatal Network and Follow-Up Group. Pediatrics; 2011 Aug 17; 128(2):e348-57. PubMed ID: 21768312 [Abstract] [Full Text] [Related]
17. Stool characteristics of infants receiving short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides: a review. Scholtens PA, Goossens DA, Staiano A. World J Gastroenterol; 2014 Oct 07; 20(37):13446-52. PubMed ID: 25309075 [Abstract] [Full Text] [Related]